LOGIN IN
REGISTER
PRODUCTS
More than 5000 active chemicals with high quality for research!

Email sales@dcchemicals.com

        order@dcchemicals.com

        info@dcchemicals.com


Phone:  +86-21-58447131

Fax   +86-21-61642470

pardoprunox (SLV308)
DC6911  (CAS:269718-84-5)
(Based on popularity)
Size Price Availability
100mg USD 650 In stock
250mg USD 1100 In stock
1g USD 2100 In stock
We match the best price and quality on market.
 
 
Email: order@dcchemicals.com
Tel: +86-21-58447131
Fax:+86-21-61642470
Fields of Application :
Pardoprunox(SLV-308) is a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist; D2 (pKi = 8.1) and D3 receptor (pKi = 8.6) partial agonist (IA = 50% and 67%, respectively) and 5-HT1A receptor (pKi = 8.5) full agonist (IA
CAS Number: 269718-84-5
Purity:

>98%

Molecular Weight: 233.27
Molecular Formula: C12H15N3O2
Quality Control: HPLCNMR LC/MS(Please contact us to get the QC report)
Synonyms: SLV-308; DU-126891
Chemical Name:
Storage: 2 years -20C Powder, 2 weeks4C in DMSO,6 months-80C in DMSO
Note: Products for research use only, not for human use
Description:
Pardoprunox(SLV-308) is a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist; D2 (pKi = 8.1) and D3 receptor (pKi = 8.6) partial agonist (IA = 50% and 67%, respectively) and 5-HT1A receptor (pKi = 8.5) full agonist (IA = 100%). It also binds to D4 (pKi = 7.8), 1-adrenergic (pKi = 7.8), 2-adrenergic (pKi = 7.4), and 5-HT7 receptors (pKi = 7.2) with lower affinity.in vitro: SLV308 acted as a potent but partial D(2) receptor agonist (pEC(50) = 8.0 and pA(2) = 8.4) with an efficacy of 50% on forskolin stimulated cAMP accumulation. At human recombinant dopamine D(3) receptors, SLV308 acted as a partial agonist in the induction of [(35)S]GTPgammaS binding (intrinsic activity of 67%; pEC(50) = 9.2) and antagonized the dopamine induction of [(35)S]GTPgammaS binding (pA(2) = 9.0). SLV308 acted as a full 5-HT(1) (A) receptor agonist on forskolin induced cAMP accumulation at cloned human 5-HT(1) (A) receptors but with low potency (pEC(50) = 6.3). in vivo: Unified PD Rating Scale (UPDRS)-Motor score was improved in pardoprunox-treated patients (overall mean dose 23.8 mg/d; -7.3 points), as compared with placebo (-3.0 points; P = 0.0001), from baseline to end point. At end point, there were more responders (> or = 30% reduction in UPDRS-Motor score) in the pardoprunox group (50.7%) than in the placebo group (15.7%; P < 0.0001). Surprisingly in the SNc, pardoprunox (10 g kg?1, i.v.) either partially or fully suppressed the firing activity in two separate populations of DA neurons. Finally, in the DRN, pardoprunox (5-40 g kg-1, i.v.) completely suppressed the firing activity of 5-HT neurons. Moreover, the selective 5-HT(1A) receptor antagonist WAY-100,635 prevented and reversed the effects of pardoprunox. For the detailed information of pardoprunox (SLV308), the solubility of pardoprunox (SLV308) in water, the solubility of pardoprunox (SLV308) in DMSO, the solubility of pardoprunox (SLV308) in PBS buffer, the animal experiment (test) of pardoprunox (SLV308), the cell expriment (test) of pardoprunox (SLV308), the in vivo, in vitro and clinical trial test of pardoprunox (SLV308), the EC50, IC50,and affinity,of pardoprunox (SLV308), For the detailed information of pardoprunox (SLV308), the solubility of pardoprunox (SLV308) in water, the solubility of pardoprunox (SLV308) in DMSO, the solubility of pardoprunox (SLV308) in PBS buffer, the animal experiment (test) of pardoprunox (SLV308), the cell expriment (test) of pardoprunox (SLV308), the in vivo, in vitro and clinical trial test of pardoprunox (SLV308), the EC50, IC50,and affinity,of pardoprunox (SLV308), Please contact DC Chemicals.
References:
CN1CCN(CC1)C2=CC=CC3=C2OC(=O)N3
About us Products Services ordering sitemap
Phone: +86-21-58447131Fax: +86-21-61642470
ADDRoom 610, Building 15, Jinxiang Rd 201, Pudong,Shanghai, China
CopyRight-2010-2013 DC Chemicals All Rights Reserved